Android app Apple app link

Fate Therapeutics, Inc. (FATE) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.28
Day's range
$1.38

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
06/08/2026 H.C. Wainwright Debjit Chattopadhyay $7.00 $1.98   253.54%
11/13/2024 BMO Capital Etzer Darout $5.00 $3.37   48.37%
08/14/2024 Stifel Nicolaus Benjamin Burnett $5.00 $3.27   52.91%
06/16/2024 Piper Sandler Edward Tenthoff $6.00 $3.61   66.44%
05/16/2024 H.C. Wainwright Debjit Chattopadhyay $5.00 $4.24   17.92%
05/10/2024 Piper Sandler Edward Tenthoff $4.00 $3.88   3.09%
05/10/2024 BMO Capital Etzer Darout $6.00 $3.87   55.24%
05/10/2024 Canaccord Genuity Bill Maughan $9.00 $3.90   130.77%
01/05/2023 Truist Financial Robyn Karnauskas $7.00 $11.00   -36.36%
12/14/2022 Goldman Sachs Andrea Tan $10.00 $15.37   -34.94%
12/12/2021 Oppenheimer Matthew Biegler $135.00 $48.98   175.62%
11/07/2021 Citigroup Yigal Nochomovitz $87.00 $60.79   43.12%
11/04/2021 Roth Capital Anthony Butler $60.00 $61.42   -2.31%
10/24/2021 Jefferies Michael Yee $145.00 $58.16   149.31%
08/19/2021 Piper Sandler Edward Tenthoff $113.00 $67.01   68.63%

Fate Therapeutics Inc FAQ's

Fate Therapeutics Inc has been rated by research analysts at Piper Sandler, Wells Fargo, H.C. Wainwright, Jefferies, Stifel Nicolaus, BMO Capital in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.